Cutaneous desmop astic melanoma - Reappraisal of morphologic heterogeneity and prognostic factors

被引:152
作者
Busam, KJ
Mujumdar, U
Hummer, AJ
Nobrega, J
Hawkins, WG
Coit, DG
Brady, MS
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
关键词
desmoplastic; melanoma; prognostic factors;
D O I
10.1097/01.pas.0000141391.91677.a4
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Desmoplastic melanoma (DM) is a variant of melanoma, which may be confused with nonmelanocytic benign or malignant spindle cell proliferations. The histologic hallmark of DM is the presence of fusiform melanocytes dispersed in a prominent collagenous stroma. Phenotypic heterogeneity of DM is underrecognized. Desmoplasia may be prominent throughout the entire tumor ("pure" DM) or represent a portion of an otherwise nondesmoplastic melanoma ("combined" DM). We reviewed melanomas with desmoplasia from 92 patients seen at a single institution between 1980 and 2002. Fifty-five of the tumors were pure DM. Thirty-seven were classified as combined. Mean follow-up of patients was 46 months for those alive at the last follow-up. Univariate analysis of clinical and pathologic parameters revealed four significant variables for disease-free survival: Clark level (IV vs. V; P = 0.005), DM subtype (pure vs. combined; P = 0.01), tumor mitotic rate (<1, 1-4, >4 mitoses/mm(2); P = 0.01), and tumor thickness (<1 mm, 1-4 mm, >4 mm; P = 0.02). Only histologic subtype (P = 0.02) and Clark level (P = 0.05) were independently significant by Cox regression analysis. Our results indicate that distinguishing pure from combined forms of DM is clinically relevant for prognosis (pure forms being associated with longer disease-specific survival). Failure to make this distinction may account for conflicting reports in the literature on the biologic behavior and prognosis of DM.
引用
收藏
页码:1518 / 1525
页数:8
相关论文
共 35 条
[21]  
2-L
[22]   Desmoplastic and spindle-cell malignant melanoma - An immunohistochemical study [J].
Longacre, TA ;
Egbert, BM ;
Rouse, RV .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (12) :1489-1500
[23]  
Payne WG, 2001, AM SURGEON, V67, P1004
[24]  
Quinn MJ, 1998, CANCER-AM CANCER SOC, V83, P1128, DOI 10.1002/(SICI)1097-0142(19980915)83:6<1128::AID-CNCR11>3.3.CO
[25]  
2-Y
[26]   NEUROTROPIC MELANOMA - VARIANT OF DESMOPLASTIC MELANOMA [J].
REED, RJ ;
LEONARD, DD .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1979, 3 (04) :301-311
[27]   DESMOPLASTIC MALIGNANT-MELANOMA [J].
SKELTON, HG ;
SMITH, KJ ;
LASKIN, WB ;
MCCARTHY, WF ;
GAGNIER, JM ;
GRAHAM, JH ;
LUPTON, GP .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995, 32 (05) :717-725
[28]   DESMOPLASTIC MELANOMA - PATTERNS OF RECURRENCE [J].
SMITHERS, BM ;
MCLEOD, GR ;
LITTLE, JH .
WORLD JOURNAL OF SURGERY, 1992, 16 (02) :186-190
[29]   Analysis of histopathological factors associated with prolonged survival of 10 years or more for patients with thick melanomas (&gt;5mm) [J].
Spatz, A ;
Shaw, HM ;
Crotty, KA ;
Thompson, JF ;
McCarthy, SW .
HISTOPATHOLOGY, 1998, 33 (05) :406-413
[30]  
SPITZ JL, 1995, CUTIS, V55, P40